Background
Globally, the HIV
epidemic continues to represent a pressing public health issue in Europe and
elsewhere. There is an emerging and progressively urgent need to harmonise HIV
and STI behavioural surveillance among MSM across European countries through
the adoption of common indicators, as well as the development of trend analysis
in order to monitor the HIV-STI epidemic over time. The Sialon II project
protocols have been elaborated for the purpose of implementing a large-scale
bio-behavioural survey among MSM in Europe in line with a Second Generation
Surveillance System (SGSS) approach.
Methods/Design
Sialon II is a
multi-centre biological and behavioural cross-sectional survey carried out
across 13 European countries (Belgium, Bulgaria, Germany, Italy, Lithuania,
Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the UK) in
community settings. A total of 4,966 MSM were enrolled in the study (3,661
participants in the TLS survey, 1,305 participants in the RDS survey). Three
distinct components are foreseen in the study protocols: first, a preliminary
formative research in each participating country. Second, collection of primary
data using two sampling methods designed specifically for ‘hard-to-reach’
populations, namely Time Location Sampling (TLS) and Respondent Driven Sampling
(RDS). Third, implementation of a targeted HIV/STI prevention campaign in the
broader context of the data collection.
Discussion
Through the
implementation of combined and targeted prevention complemented by meaningful
surveillance among MSM, Sialon II represents a unique opportunity to pilot a
bio-behavioural survey in community settings in line with the SGSS approach in
a large number of EU countries. Data generated through this survey will not
only provide a valuable snapshot of the HIV epidemic in MSM but will also offer
an important trend analysis of the epidemiology of HIV and other STIs over time
across Europe. Therefore, the Sialon II protocol and findings are likely to
contribute significantly to increasing the comparability of data in EU
countries through the use of common indicators and in contributing to the
development of effective public health strategies and policies in areas of high
need.
Purchase full article at: http://goo.gl/ww013K
By: 
Massimo
Mirandola, Igor
Toskin, Ulrich
Marcus, Sandra
Dudareva-Vizule, Nigel
Sherriff, Michele
Breveglieri, Martina
Furegato, Cinta
Folch, Laia
Ferrer, Alexandra
Montoliu, Christiana
Nöstlinger, Wim Vanden
Berghe,Sharon
Kühlmann-Berenzon, Inga
Velicko, Sónia Dias, Barbara
Suligoi, Vincenza
Regine, Danica
Stanekova,Magdalena
Rosińska, Saulius
Caplinskas, Irena
Klavs, Ivailo
Alexiev, and Alexandru
Rafila
Massimo
Mirandola, Igor
Toskin, Ulrich
Marcus, Sandra
Dudareva-Vizule, Nigel
Sherriff, Michele
Breveglieri, Martina
Furegato, Cinta
Folch, Laia
Ferrer, Alexandra
Montoliu, Christiana
Nöstlinger, Wim Vanden
Berghe,Sharon
Kühlmann-Berenzon, Inga
Velicko, Sónia Dias, Barbara
Suligoi, Vincenza
Regine, Danica
Stanekova,Magdalena
Rosińska, Saulius
Caplinskas, Irena
Klavs, Ivailo
Alexiev, and Alexandru
Rafila
Veneto Region -
Department of Health, CReMPE - Regional Coordination Centre for European
Project Management, the Verona University Hospital, Verona, Italy
Department of
Pathology, Infectious Diseases Section, the Verona University Hospital - Veneto
Region, Verona, Italy
Department of
Reproductive Health & Research, World Health Organization, Geneva,
Switzerland
Department for
Infectious Diseases Epidemiology, Robert Koch-Institute, Berlin, Germany
Centre for Health
Research, University of Brighton, Brighton, UK
Institut Catala
d’Oncologia (ICO), Centre for Epidemiological Studies on HIV/STI in Catalonia
(CEEISCAT), Agencia de Salut Publica de Catalunya (ASPC), Hospital Universitari
Germans Trias i Pujol, Barcelona, Spain
Department of
Public Health, Institute of Tropical Medicine, Antwerp, Belgium
Department of
Monitoring and Evaluation, Public Health Agency of Sweden, Solna, Sweden
Institute of
Hygiene and Tropical Medicine & GHTM, Universidade Nova de Lisboa, Lisbon,
Portugal
Centro Operativo
AIDS, Dipartimento di Malattie Infettive, Parassitarie ed Immunomediate,
Istituto Superiore di Sanità, Rome, Italy
NRC for HIV/AIDS,
Slovak Medical University, Bratislava, Slovak Republic
Department of
Epidemiology, National Institute of Public Health, National Institute of
Hygiene, Warsaw, Poland
Centre for
Communicable Diseases and AIDS, Vilnius, Lithuania
National
Institute of Public Health, Ljubljana, Slovenia
National
Reference Laboratory of HIV, National Center of Infectious and Parasitic
Diseases, Sofia, Bulgaria
National
Institute of Infectious Diseases Prof. Dr. Matei Bals, Bucharest, Romania
Lorenzo Gios, Email: moc.liamg@oznerol.soig, Email: ti.anorevinueladepso@soig.oznerol.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment